脱血性药物喷发和传染性单核病之间的代谢差异
Yanqiu Liu1, Qizhen Guan1, Liyuan Liu1
1Department of Dermatology and Venereology, The Affiliated Hospital of Chengde Medical University, Chengde, China.
概括
代谢分析揭示了在外血性药物爆发和传染性单核病 (IM) 中不同的代谢模式. 这些差异突出了这些外血性疾病的病原发生所涉及的独特途径.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 代谢学 代谢学 代谢学
背景情况:
- 脱血性药物喷发和传染性单核病 (IM) 是常见的脱血性疾病.
- 之前的研究集中在鉴定上,缺乏系统的代谢分析.
- 这些疾病之间的代谢差异在很大程度上仍未被探索.
研究的目的:
- 系统地分析和比较血清新陈代谢特征的exanthematous药物喷发和IM.
- 为了确定区分这两个条件的潜在代谢生物标志物.
- 阐明潜在的代谢途径,有助于每个疾病的发病.
主要方法:
- 分析了30名患有血性药物喷发或IM的患者,10名没有血的患者和10名健康志愿者的血清样本.
- 采用了基于气色谱-质谱学 (GC-MS) 的代谢学.
- 禁食静脉血液被收集用于代谢物分析.
主要成果:
- 确定了165种代谢物,在外血性药物喷发和IM组之间存在显著差异.
- 对28种潜在的生物标志物进行了精确的鉴定,这些生物标志物显示出改变的酸路径 (PPP),三酸循环 (TCA循环) 和银河糖代谢.
- 在脱血性药物喷发中观察到不同的代谢途径,包括氨酸/氨酸代谢和TCA,这表明缺氧压力;IM组显示TCA和氨基酸代谢的变化,表明能量生成和炎症作用.
结论:
- 血清代谢分析揭示了脱血性药物喷发和IM的独特模式.
- 这些独特的代谢特征与这两种疾病的不同致病性密切相关.
- 这些发现为外血性药物爆发和IM的代谢基础提供了新的见解.
相关概念视频
Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...


